Education
- 2024: National scientific qualification as Associate Professor of Cardiovascular Diseases
- 2021 – 2024: PhD in Data Science in Medicine and Nutrition, Humanitas University, Pieve Emanuele, Milan, Italy
- 2016 – 2020: Residency in Cardiovascular Diseases, Humanitas University, Milan, Italy
- 2009 – 2015: Doctor of Medicine, graduated cum laude and honor mention at Vita-Salute San Raffaele University, Milan, Italy
Academic Appointments
- 2026 – present: RTT (Assistant Professor), Cardiovascular Disease (MED/11), Humanitas University, Pieve Emanuele, Milan
- 2022 – 2026: RTDA, Cardiovascular Disease (MED/11), Humanitas University, Pieve Emanuele, Milan
- 2021 – 2022: Adjunct Teaching Professor, Cardiovascular Disease (MED/11), Humanitas University, Pieve Emanuele, Milan
Awards and Honors
- 2022: Best Abstract Award – 83rd National Congress, Italian Society of Cardiology (SIC)
- 2021: Grant from Fondazione Humanitas per la Ricerca, IRCCS Istituto Clinico Humanitas (5×1000 Funds)
- 2021: Bando Ricerca Finalizzata – Giovani Ricercatori, Ministry of Health
- 2020: Grant from Fondazione Humanitas per la Ricerca, IRCCS Istituto Clinico Humanitas (5×1000 Funds)
- 2019: Best Abstract Award, Italian Society of Cardiology (SIC)
Other
- 2020 – present: Cardiac Intensive Care Unit, Clinical and Interventional Cardiology, Cardiovascular Department, IRCCS Istituto Clinico Humanitas, Rozzano, Milan
- 2021: Heart failure and cardiogenic shock
- 2018: risk prediction in cardiovascular diseases
- 2017: heart valve diseases
- 2015: Acute and chronic coronary syndromes
- 2015: antithrombotic therapy
- Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. M Chiarito, J Sanz-Sánchez, F Cannata, D Cao, M Sturla, C Panico, et al. The Lancet 395 (10235), 1487-1495.
- A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry R Mehran, R Owen, M Chiarito, U Baber, S Sartori, D Cao, J Nicolas, et al. The Lancet 398 (10315), 1974-1983.
- Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort. M Chiarito, D Stolfo, A Villaschi, S Sartori, L Baldetti, CM Lombardi, European Journal of Heart Failure 27 (4), 726-7364.
- Prevalence and impact of high bleeding risk in patients undergoing left main artery disease PCI. M Chiarito, A Kini, A Roumeliotis, D Cao, D Power, S Sartori, A Reisman, et al. JACC Cardiovascular Interventions 14 (22), 2447-2457
- Ticagrelor monotherapy after PCI in high-risk patients with prior MI: a prespecified TWILIGHT substudy. M Chiarito, U Baber, D Cao, SK Sharma, G Dangas, DJ Angiolillo, et al. JACC Cardiovascular Interventions 15 (3), 282-293.